Cargando…
Rapid Adaptation of Established High-Throughput Molecular Testing Infrastructure for Monkeypox Virus Detection
Beginning in May 2022, a rising number of monkeypox cases were reported in non–monkeypox-endemic countries in the Northern Hemisphere. We adapted 2 published quantitative PCRs for use as a dual-target monkeypox virus test on widely used automated high-throughput PCR systems. We determined analytic p...
Autores principales: | Nörz, Dominik, Tang, Hui Ting, Emmerich, Petra, Giersch, Katja, Fischer, Nicole, Schmiedel, Stephan, Addo, Marylyn M., Aepfelbacher, Martin, Pfefferle, Susanne, Lütgehetmann, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423910/ https://www.ncbi.nlm.nih.gov/pubmed/35905463 http://dx.doi.org/10.3201/eid2809.220917 |
Ejemplares similares
-
Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform
por: Nörz, Dominik, et al.
Publicado: (2021) -
Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022
por: Nörz, Dominik, et al.
Publicado: (2022) -
Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7
por: Nörz, Dominik, et al.
Publicado: (2021) -
Clinical Evaluation of a Fully-Automated High-Throughput Multiplex Screening-Assay to Detect and Differentiate the SARS-CoV-2 B.1.1.529 (Omicron) and B.1.617.2 (Delta) Lineage Variants
por: Nörz, Dominik, et al.
Publicado: (2022) -
Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022)